| Literature DB >> 30917920 |
Yurie Kinoshita1, Jian Xu2, Akitsu Masuda1, Kosuke Minamihata3, Noriho Kamiya4, Hiroaki Mon1, Ryosuke Fujita5, Takahiro Kusakabe1, Jae Man Lee6.
Abstract
Human granulocyte-macrophage colony stimulating factor (hGM-CSF) is a hematopoietic growth factor. It is widely employed as a therapeutic agent targeting neutropenia in cancer patients undergoing chemotherapy and in patients with AIDS or after bone marrow transplantation. In this study, we constructed the recombinant baculoviruses for the expression of recombinant hGM-CSF (rhGM-CSF) with two small affinity tags (His-tag and Strep-tag) at the N or C-terminus. Compared to N-tagged rhGM-CSF, C-tagged rhGM-CSF was highly recovered from silkworm hemolymph. The purified rhGM-CSF proteins migrated as a diffuse band and were confirmed to hold N-glycosylations. A comparable activity was achieved when commercial hGM-CSF was tested as a control. Considering the high price of hGM-CSF in the market, our results and strategies using silkworm-baculovirus system can become a great reference for mass production of the active rhGM-CSF at a lower cost.Entities:
Keywords: Granulocyte-macrophage colony-stimulating factor; Recombinant proteins; Silkworm-baculovirus expression system
Mesh:
Substances:
Year: 2019 PMID: 30917920 DOI: 10.1016/j.pep.2019.03.010
Source DB: PubMed Journal: Protein Expr Purif ISSN: 1046-5928 Impact factor: 1.650